Journey Medical (DERM) Cost of Revenue (2020 - 2026)
Journey Medical's (DERM) quarterly Cost of Revenue came in at $6.2 million in Q1 2026, up 29.81% YoY from $4.8 million in Q1 2025, and up 14.3% on a QoQ basis from $5.4 million in Q4 2025.
Journey Medical (DERM) Cost of Revenue (2020 - 2026) Analysis & Trends
Journey Medical (DERM) has 7 years of Cost of Revenue data on file, last reported at $6.2 million in Q1 2026.
- Quarterly Cost of Revenue rose 29.81% year-over-year to $6.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $22.4 million (up 13.65% YoY) and the FY2025 annual result came in at $20.9 million, changed 0.22% from the prior year.
- Cost of Revenue rose to $6.2 million in Q1 2026, from $5.4 million in the prior quarter.
- In the past five years, Cost of Revenue ranged from a high of $8.2 million in Q1 2022 to a low of $2.2 million in Q4 2023.
- A 5-year average of $6.0 million and a median of $6.0 million in 2024 frame the typical range for Cost of Revenue.
- Annual changes were most pronounced in 2022 — Cost of Revenue jumped 109.9% — and 2023, when it plunged 70.87%.
- Tracing DERM's Cost of Revenue over 5 years: stood at $7.7 million in 2022, then sank by 70.87% to $2.2 million in 2023, then soared by 108.19% to $4.7 million in 2024, then climbed by 16.24% to $5.4 million in 2025, then grew by 14.3% to $6.2 million in 2026.
- The last three Cost of Revenue figures came in at $6.2 million (Q1 2026), $5.4 million (Q4 2025), and $5.8 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cost of Rev (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.81 Bn | 42.84 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.29 Bn | 39.63 Bn | 2.15 Bn | 1.99 Bn |
| 3 | Zoetis | 31.59 Bn | 29.91 Bn | 1.05 Bn | 673.00 Mn |
| 4 | Takeda Pharmaceutical | 28.67 Bn | 22.88 Bn | 5.10 Bn | 2.55 Bn |
| 5 | United Therapeutics | 22.24 Bn | 19.58 Bn | 683.80 Mn | 99.50 Mn |
| 6 | Viatris | 18.79 Bn | 17.91 Bn | 1.46 Bn | 2.30 Bn |
| 7 | Neurocrine Biosciences | 15.71 Bn | 15.32 Bn | 935.80 Mn | 23.20 Mn |
| 8 | Elanco Animal Health | 12.09 Bn | 11.56 Bn | 798.00 Mn | 570.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.95 Bn | - | - |
| 10 | Journey Medical | 205.93 Mn | 180.28 Mn | 12.37 Mn | 6.14 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 6.14 Mn |
| Jun 30, 2026 | 6.14 Mn |
| Mar 31, 2026 | 6.22 Mn |
| Mar 31, 2026 | 6.22 Mn |
| Dec 31, 2025 | 5.44 Mn |
| Dec 31, 2025 | 5.44 Mn |
| Sep 30, 2025 | 5.76 Mn |
| Sep 30, 2025 | 5.76 Mn |
| Jun 30, 2025 | 4.94 Mn |
| Jun 30, 2025 | 4.94 Mn |
| Mar 31, 2025 | 4.79 Mn |
| Mar 31, 2025 | 4.79 Mn |
| Dec 31, 2024 | 4.68 Mn |
| Dec 31, 2024 | 4.68 Mn |
| Sep 30, 2024 | 4.47 Mn |
| Sep 30, 2024 | 4.47 Mn |
| Jun 30, 2024 | 5.73 Mn |
| Jun 30, 2024 | 5.73 Mn |
| Mar 31, 2024 | 6.00 Mn |
| Mar 31, 2024 | 6.00 Mn |